Fluid overload due to intravenous fluid therapy for vaso‐occlusive crisis in sickle cell disease: incidence and risk factors

Intravenous fluid therapy (IV‐FT) is routinely used in the treatment of vaso‐occlusive crises (VOCs), as dehydration possibly promotes and sustains erythrocyte sickling. Patients with sickle cell disease (SCD) are at risk of developing diastolic dysfunction and fluid overload due to IV‐FT. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaartman, Aafke E., Sayedi, Ajab K., Gerritsma, Jorn J., de Back, Tim R., van Tuijn, Charlotte F., Tang, Man Wai, Heijboer, Harriët, de Heer, Koen, Biemond, Bart J., Nur, Erfan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Haemoglobinopathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456906/
https://www.ncbi.nlm.nih.gov/pubmed/34263922
http://dx.doi.org/10.1111/bjh.17696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456906/
https://www.ncbi.nlm.nih.gov/pubmed/34263922
http://dx.doi.org/10.1111/bjh.17696

Ejemplares similares